» Articles » PMID: 24588809

Development and Antimicrobial Susceptibility Studies of in Vitro Monomicrobial and Polymicrobial Biofilm Models with Aspergillus Fumigatus and Pseudomonas Aeruginosa

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2014 Mar 5
PMID 24588809
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mixed microbial infections of the respiratory tracts with P. aeruginosa and A. fumigatus capable of producing biofilms are commonly found in cystic fibrosis patients. The primary objective of this study was to develop an in vitro model for P. aeruginosa and A. fumigatus polymicrobial biofilm to study the efficacy of various antimicrobial drugs alone and in combinations against biofilm-embedded cells. Simultaneous static cocultures of P. aeruginosa and sporelings were used for the development of in vitro P. aeruginosa-A. fumigatus polymicrobial biofilm in SD broth in 24-well cell culture plates at 35°C, and the biofilm formation was monitored microscopically and spectrophotometrically. Using P. aeruginosa-A. fumigatus sporelings cocultures we examined the effects of various antimicrobial drugs alone and in combination against polymicrobial biofilm by CFU and tetrazolium reduction assays.

Results: In simultaneous static cocultures P. aeruginosa cells killed A. fumigatus conidia, whereas the bacterial cells showed no substantial fungicidal effect on sporelings grown for 12 h or longer at 35°C. Monospecies cultures of P. aeruginosa produced loosely adhered monomicrobial biofilm and addition of 10% bovine serum to the growth medium inhibited the formation of monomicrobial biofilm by P. aeruginosa whereas it produced tightly adhered polymicrobial biofilm in the presence of A. fumigatus mycelial growth. A. fumigatus produced firmly adherent monomicrobial and polymicrobial biofilms. A comparison of CFU and MTT assays showed that the latter is unsuitable for studying the effectiveness of antimicrobial treatment against polymicrobial biofilm. Tobramycin alone and in combination with posaconazole was highly effective against monomicrobial and polymicrobial biofilms of P. aeruginosa whereas cefepime alone and in combination with posaconazole showed excellent activity against monomicrobial biofilm of P. aeruginosa but was less effective against polymicrobial biofilm. Monomicrobial and polymicrobial biofilms of A. fumigatus showed similar susceptibility to posaconazole with and without the antibacterial drug.

Conclusions: Simultaneous static coculture of A. fumigatus sporelings grown for 12 h or longer was superior to ungerminated conidia with P. aeruginosa for the development of A. fumigatus-P. aeruginosa biofilm. P. aeruginosa-A. fumigatus polymicrobial biofilm shows differential susceptibility to antimicrobial drugs whereas the susceptibility of A. fumigatus to antimicrobial drugs was unchanged.

Citing Articles

Development of a Stringent Ex Vivo-Burned Porcine Skin Wound Model to Screen Topical Antimicrobial Agents.

Chen P, Sebastian E, Karna S, Leung K Antibiotics (Basel). 2025; 13(12.

PMID: 39766550 PMC: 11672622. DOI: 10.3390/antibiotics13121159.


Interspecies interactions alter the antibiotic sensitivity of .

Koumans C, Tandar S, Liakopoulos A, van Hasselt J Microbiol Spectr. 2024; :e0201224.

PMID: 39495005 PMC: 11619387. DOI: 10.1128/spectrum.02012-24.


Fungal biofilm formation and its regulatory mechanism.

Wang D, Zeng N, Li C, Li Z, Zhang N, Li B Heliyon. 2024; 10(12):e32766.

PMID: 38988529 PMC: 11233959. DOI: 10.1016/j.heliyon.2024.e32766.


Virtual Screening of Potential RoxS Inhibitors and Evaluation of Their Antimicrobial Activity in Combination with Antibiotics against Clinically Resistant Bacteria.

Huang Y, Li J, Liang T, Zhao Z, Xu J, Chen W Antibiotics (Basel). 2023; 12(9).

PMID: 37760718 PMC: 10525716. DOI: 10.3390/antibiotics12091422.


Interactions between Bacteria and in Airways: From the Mycobiome to Molecular Interactions.

Debourgogne A, Monpierre L, Sy K, Valsecchi I, Decousser J, Botterel F J Fungi (Basel). 2023; 9(9).

PMID: 37755008 PMC: 10533028. DOI: 10.3390/jof9090900.


References
1.
Mah T, OToole G . Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001; 9(1):34-9. DOI: 10.1016/s0966-842x(00)01913-2. View

2.
Dales L, Ferris W, Vandemheen K, Aaron S . Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2009; 28(10):1275-9. DOI: 10.1007/s10096-009-0774-9. View

3.
Sibley C, Surette M . The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can J Microbiol. 2011; 57(2):69-77. DOI: 10.1139/w10-105. View

4.
Manavathu E, Alangaden G, Chandrasekar P . Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus. J Antimicrob Chemother. 2003; 51(6):1423-5. DOI: 10.1093/jac/dkg242. View

5.
LiPuma J . The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010; 23(2):299-323. PMC: 2863368. DOI: 10.1128/CMR.00068-09. View